New cholesterol-specifi c antibodies remodel HIV-1 target cells' surface and inhibit their in vitro virus production

Journal of Lipid Research

Volumn 51, Issue 2, 2010, Pages 286-296

  Beck, Zoltán ^a,f   Balogh, Andrea ^b   Kis, Andrea ^a   Izsépi, Emese ^b   Cervenak, László ^d   László, Glória ^b   Bíró, Adrienn ^c   Liliom, Károly ^c   Mocśr, Gábor ^e   Vámosi, György ^e   Füst, George ^d   Matko, Janos ^b,c  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^d SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^e UNIVERSITY OF DEBRECEN   (Hungary)

^f HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

Author keywords

Cholesterolspecifi c IgG; HIV 1 production; HIV 1 receptors; Lipid rafts; Membrane cholesterol; Monocyte macrophage cells; T cells

Indexed keywords

CD4 ANTIBODY; CHEMOKINE RECEPTOR CXCR4; CHOLESTEROL; IMMUNOGLOBULIN G ANTIBODY; MONOCLONAL ANTIBODY; VIRUS GLYCOPROTEIN; VIRUS RECEPTOR; CD4 ANTIGEN; IMMUNOGLOBULIN G;

ARTICLE; CELL MEMBRANE; CELL SURFACE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; FLUORESCENCE CORRELATION SPECTROSCOPY; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOFLUORESCENCE; IN VITRO STUDY; LIPID RAFT; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; SURFACE PLASMON RESONANCE; T LYMPHOCYTE; VIRUS ATTACHMENT; VIRUS INHIBITION; ANIMAL; ANTIBODY SPECIFICITY; CELL LINE; DRUG EFFECT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; METABOLISM; MOUSE; MOVEMENT (PHYSIOLOGY); PHYSIOLOGY; VIROLOGY; VIRUS ENTRY; VIRUS REPLICATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS, CD4; CELL LINE; CHOLESTEROL; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOGLOBULIN G; MACROPHAGES; MEMBRANE MICRODOMAINS; MICE; MOVEMENT; RECEPTORS, CXCR4; SURFACE PLASMON RESONANCE; T-LYMPHOCYTES; VIRUS ATTACHMENT; VIRUS INTERNALIZATION; VIRUS REPLICATION;

EID: 77949503413     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M000372     Document Type: Article

References (37)

1. Alving, C. R., and N. M. Wassef. 1999. Naturally occurring antibod-ies to cholesterol: a new theory of LDL cholesterol metabolism. Immunol. Today. 20: 362-366.
2. Biro, A., L. Cervenak, A. Balogh, A. Lorincz, K. Uray, A. Horvath, L. Romics, J. Matko, G. Fust, and G. Laszlo. 2007. Novel anti-cholesterol monoclonal immunoglobulin G antibodies as probes and potential modulators of membrane raft-dependent immune functions. J. Lipid Res. 48: 19-29.
3. Matko, J., and J. Szollosi. 2005. Regulatory aspects of membrane mi-crodomain (raft) dynamics in live cells. In Membrane Microdomain Signaling: Lipid Rafts in Biology and Medicine. M. P. Mattson, editor. Humana Press, Totowa, NJ. 15-46.
4. Pike, L. J. 2003. Lipid rafts: bringing order to chaos. J. Lipid Res. 44: 655-667.
5. Hug, P., H. M. Lin, T. Korte, X. Xiao, D. S. Dimitrov, J. M. Wang, A. Puri, and R. Blumenthal. 2000. Glycosphingolipids promote entry of a broad range of human immunodefi ciency virus type 1 isolates into cell lines expressing CD4, CXCR4, and/or CCR5. J. Virol. 74: 6377-6385.
6. Manes, S., G. del Real, R. A. Lacalle, P. Lucas, C. Gomez-Mouton, S. Sanchez-Palomino, R. Delgado, J. Alcami, E. Mira, and A. C. Martinez. 2000. Membrane raft microdomains mediate lateral assemblies required for HIV-1 infection. EMBO Rep. 1: 190-196.
7. Nisole, S., B. Krust, and A. G. Hovanessian. 2002. Anchorage of HIV on permissive cells leads to coaggregation of viral particles with surface nucleolin at membrane raft microdomains. Exp. Cell Res. 276: 155-173.
8. Fantini, J., N. Garmy, R. Mahfoud, and N. Yahi. 2002. Lipid rafts: structure, function and role in HIV, Alzheimer's and prion diseases. Expert Rev. Mol. Med. 4: 1-22.
9. Jolly, C., and Q. J. Sattentau. 2005. Human immunodefi ciency virus type 1 virological synapse formation in T cells requires lipid raft integrity. J. Virol. 79: 12088-12094.
10. Nguyen, D. H., and J. E. Hildreth. 2000. Evidence for budding of human immunodefi ciency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J. Virol. 74: 3264-3272.
11. Popik, W., T. M. Alce, and W. C. Au. 2002. Human immunodefi-ciency virus type 1 uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4(+) T cells. J. Virol. 76: 4709-4722.
12. Nguyen, D. H., B. Giri, G. Collins, and D. D. Taub. 2005. Dynamic reorganization of chemokine receptors, cholesterol, lipid rafts, and adhesion molecules to sites of CD4 engagement. Exp. Cell Res. 304: 559-569.
13. Brown, B. K., N. Karasavvas, Z. Beck, G. R. Matyas, D. L. Birx, V. R. Polonis, and C. R. Alving. 2007. Monoclonal antibodies to phosphatidylinositol phosphate neutralize human immunodefi-ciency virus type 1: role of phosphate-binding subsites. J. Virol. 81: 2087-2091.
14. Adamczyk, M., J. C. Gebler, and J. Wu. 2000. Papain digestion of different mouse IgG subclasses as studied by electrospray mass spectrometry. J. Immunol. Methods. 237: 95-104.
15. Costes, S. V., D. Daelemans, E. H. Cho, Z. Dobbin, G. Pavlakis, and S. Lockett. 2004. Automatic and quantitative measurement of protein-protein colocalization in live cells. Biophys. J. 86: 3993-4003.
16. Roszik, J., D. Lisboa, J. Szollosi, and G. Vereb. 2009. Evaluation of intensity-based ratiometric FRET in image cytometry-approaches and a software solution. Cytometry A. 75: 761-777.
17. Haustein, E., and P. Schwille. 2007. Fluorescence correlation spec-troscopy: novel variations of an established technique. Annu. Rev. Biophys. Biomol. Struct. 36: 151-169.
18. Gombos, I., G. Steinbach, I. Pomozi, A. Balogh, G. Vamosi, A. Gansen, G. Laszlo, G. Garab, and J. Matko. 2008. Some new faces of membrane microdomains: a complex confocal fl uorescence, differential polarization, and FCS imaging study on live immune cells. Cytometry A. 73: 220-229.
19. Gendelman, H. E., J. M. Orenstein, M. A. Martin, C. Ferrua, R. Mitra, T. Phipps, L. A. Wahl, H. C. Lane, A. S. Fauci, D. S. Burke, et al. 1988. Effi cient isolation and propagation of human immuno-defi ciency virus on recombinant colony-stimulating factor 1-treated monocytes. J. Exp. Med. 167: 1428-1441.
20. Wong-Staal, F., G. M. Shaw, B. H. Hahn, S. Z. Salahuddin, M. Popovic, P. Markham, R. Redfi eld, and R. C. Gallo. 1985. Genomic diversity of human T-lymphotropic virus type III (HTLV-III). Science. 229: 759-762. (Pubitemid 15049818)
21. Hoffman, A. D., B. Banapour, and J. A. Levy. 1985. Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions. Virology. 147: 326-335.
22. Zhao, Q., J. T. Ernst, A. D. Hamilton, A. K. Debnath, and S. Jiang. 2002. XTT formazan widely used to detect cell viability inhibits HIV type 1 infection in vitro by targeting gp41. AIDS Res. Hum. Retroviruses. 18: 989-997.
23. Rey, M., A. Valenzuela-Fernandez, A. Urzainqui, M. Yanez-Mo, M. Perez-Martinez, P. Penela, F. Mayor, Jr., and F. Sanchez-Madrid. 2007. Myosin IIA is involved in the endocytosis of CXCR4 induced by SDF-1alpha. J. Cell Sci. 120: 1126-1133.
24. Xiao, X., L. Wu, T. S. Stantchev, Y. R. Feng, S. Ugolini, H. Chen, Z. Shen, J. L. Riley, C. C. Broder, Q. J. Sattentau, et al. 1999. Constitutive cell surface association between CD4 and CCR5. Proc. Natl. Acad. Sci. USA. 96: 7496-7501.
25. Bacia, K., P. Schwille, and T. Kurzchalia. 2005. Sterol structure de-termines the separation of phases and the curvature of the liquid-ordered phase in model membranes. Proc. Natl. Acad. Sci. USA. 102: 3272-3277.
26. Alving, C. R., Z. Beck, N. Karasavva, G. R. Matyas, and M. Rao. 2006. HIV-1, lipid rafts, and antibodies to liposomes: implications for anti-viral-neutralizing antibodies. Mol. Membr. Biol. 23: 453-465.
27. Haynes, B. F., J. Fleming, E. W. St Clair, H. Katinger, G. Stiegler, R. Kunert, J. Robinson, R. M. Scearce, K. Plonk, H. F. Staats, et al. 2005. Cardiolipin polyspecifi c autoreactivity in two broadly neutralizing HIV-1 antibodies. Science. 308: 1906-1908.
28. Harder, T., P. Scheiffele, P. Verkade, and K. Simons. 1998. Lipid domain structure of the plasma membrane revealed by patching of membrane components. J. Cell Biol. 141: 929-942.
29. Charrin, S., S. Manie, C. Thiele, M. Billard, D. Gerlier, C. Boucheix, and E. Rubinstein. 2003. A physical and functional link between cholesterol and tetraspanins. Eur. J. Immunol. 33: 2479-2489.
30. Kozak, S. L., J. M. Heard, and D. Kabat. 2002. Segregation of CD4 and CXCR4 into distinct lipid microdomains in T lymphocytes suggests a mechanism for membrane destabilization by human immu-nodefi ciency virus. J. Virol. 76: 1802-1815.
31. Singer, I. I., S. Scott, D. W. Kawka, J. Chin, B. L. Daugherty, J. A. DeMartino, J. DiSalvo, S. L. Gould, J. E. Lineberger, L. Malkowitz, et al. 2001. CCR5, CXCR4, and CD4 are clustered and closely ap-posed on microvilli of human macrophages and T cells. J. Virol. 75: 3779-3790.
32. Viard, M., I. Parolini, M. Sargiacomo, K. Fecchi, C. Ramoni, S. Ablan, F. W. Ruscetti, J. M. Wang, and R. Blumenthal. 2002. Role of cholesterol in human immunodefi ciency virus type 1 envelope protein-mediated fusion with host cells. J. Virol. 76: 11584-11595.
33. Hovanessian, A. G., J. P. Briand, E. A. Said, J. Svab, S. Ferris, H. Dali, S. Muller, C. Desgranges, and B. Krust. 2004. The caveolin-1 binding domain of HIV-1 glycoprotein gp41 is an effi cient B cell epitope vaccine candidate against virus infection. Immunity. 21: 617-627.
34. Nagy, P., G. Vereb, Z. Sebestyen, G. Horvath, S. J. Lockett, S. Damjanovich, J. W. Park, T. M. Jovin, and J. Szollosi. 2002. Lipid rafts and the local density of ErbB proteins infl uence the biological role of homo-and heteroassociations of ErbB2. J. Cell Sci. 115: 4251-4262.
35. Beck, Z., N. Karasavvas, G. R. Matyas, and C. R. Alving. 2008. Membrane-specifi c antibodies induced by liposomes can simultaneously bind to HIV-1 protein, peptide, and membrane lipid epitopes. J. Drug Target. 16: 535-542.
36. Haynes, B. F., and S. M. Alam. 2008. HIV-1 hides an Achilles' heel in virion lipids. Immunity. 28: 10-12.
37. Phogat, S., R. T. Wyatt, and G. B. Karlsson Hedestam. 2007. Inhibition of HIV-1 entry by antibodies: potential viral and cellular targets. J. Intern. Med. 262: 26-43.